Artificial intelligence-enabled pharmaceutical company Atomwise has appointed Jeffrey Cerio to the newly created role of general counsel.

Cerio, who will also serve as corporate secretary, joins San Francisco-based Atomwise from Triplet Therapeutics, where he was general counsel and corporate secretary for nearly two years. Before that, he served as senior corporate counsel of securities at Moderna, where he led the company through its $604M IPO.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]